Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,608 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Percutaneous coronary revascularization in coronary artery disease: lessons from a single center experience.
Aksoy O, Tuzcu EM, Ellis SG, Whitlow PL, Cam A, Batizy L, Agarwal S, Franco I, Bajzer C, Simpfendorfer C, Raymond R, Nair R, Cho L, Shishehbor MH, Lincoff AM, Kapadia SR. Aksoy O, et al. Among authors: nair r. Catheter Cardiovasc Interv. 2013 Jan 1;81(1):E1-8. doi: 10.1002/ccd.24442. Epub 2012 Nov 8. Catheter Cardiovasc Interv. 2013. PMID: 22508442
A novel point-of-care enoxaparin monitor for use during percutaneous coronary intervention. Results of the Evaluating Enoxaparin Clotting Times (ELECT) Study.
Moliterno DJ, Hermiller JB, Kereiakes DJ, Yow E, Applegate RJ, Braden GA, Dippel EJ, Furman MI, Grines CL, Kleiman NS, Levine GN, Mann T 3rd, Nair RN, Stine RA, Yacubov SJ, Tcheng JE; ELECT Investigators. Moliterno DJ, et al. J Am Coll Cardiol. 2003 Sep 17;42(6):1132-9. doi: 10.1016/s0735-1097(03)01053-2. J Am Coll Cardiol. 2003. PMID: 13678943 Free article.
Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial.
Nissen SE, Nicholls SJ, Wolski K, Nesto R, Kupfer S, Perez A, Jure H, De Larochellière R, Staniloae CS, Mavromatis K, Saw J, Hu B, Lincoff AM, Tuzcu EM; PERISCOPE Investigators. Nissen SE, et al. JAMA. 2008 Apr 2;299(13):1561-73. doi: 10.1001/jama.299.13.1561. Epub 2008 Mar 31. JAMA. 2008. PMID: 18378631 Clinical Trial.
Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial.
Nissen SE, Nicholls SJ, Wolski K, Rodés-Cabau J, Cannon CP, Deanfield JE, Després JP, Kastelein JJ, Steinhubl SR, Kapadia S, Yasin M, Ruzyllo W, Gaudin C, Job B, Hu B, Bhatt DL, Lincoff AM, Tuzcu EM; STRADIVARIUS Investigators. Nissen SE, et al. JAMA. 2008 Apr 2;299(13):1547-60. doi: 10.1001/jama.299.13.1547. Epub 2008 Apr 1. JAMA. 2008. PMID: 18387931 Clinical Trial.
Enhanced prediction of mortality after percutaneous coronary intervention by consideration of general and neurological indicators.
Ellis SG, Shishehbor MH, Kapadia SR, Lincoff AM, Nair R, Whitlow PL, Bajzer CT, Cho LL, Tuzcu EM, Raymond R, Vargo P, Cunningham R, Dushman-Ellis SJ. Ellis SG, et al. Among authors: nair r. JACC Cardiovasc Interv. 2011 Apr;4(4):442-8. doi: 10.1016/j.jcin.2011.01.006. JACC Cardiovasc Interv. 2011. PMID: 21511224 Free article.
2,608 results